183 related articles for article (PubMed ID: 24239563)
21. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
22. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
Lin CC; Lai MS; Shau WY
Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
[TBL] [Abstract][Full Text] [Related]
23. Aspirin use and survival after diagnosis of colorectal cancer.
Chan AT; Ogino S; Fuchs CS
JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
[TBL] [Abstract][Full Text] [Related]
24. Commonly used medications and endometrial cancer survival: a population-based cohort study.
Sanni OB; Mc Menamin ÚC; Cardwell CR; Sharp L; Murray LJ; Coleman HG
Br J Cancer; 2017 Jul; 117(3):432-438. PubMed ID: 28683466
[TBL] [Abstract][Full Text] [Related]
25. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
26. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004
[TBL] [Abstract][Full Text] [Related]
27. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
[TBL] [Abstract][Full Text] [Related]
28. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
[TBL] [Abstract][Full Text] [Related]
29. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
30. Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer.
Rodríguez-Miguel A; García-Rodríguez LA; Gil M; Montoya H; Rodríguez-Martín S; de Abajo FJ
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2024-2033.e2. PubMed ID: 30580092
[TBL] [Abstract][Full Text] [Related]
31. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer.
Matsuo K; Cahoon SS; Yoshihara K; Shida M; Kakuda M; Adachi S; Moeini A; Machida H; Garcia-Sayre J; Ueda Y; Enomoto T; Mikami M; Roman LD; Sood AK
Obstet Gynecol; 2016 Jul; 128(1):127-137. PubMed ID: 27275802
[TBL] [Abstract][Full Text] [Related]
32. Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study.
Shahrivar M; Weibull CE; Ekström Smedby K; Glimelius B; Syk I; Matthiessen P; Nordenvall C; Martling A
Cancer Med; 2023 Jan; 12(1):315-324. PubMed ID: 35717628
[TBL] [Abstract][Full Text] [Related]
33. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
34. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
35. Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis.
Figueiredo JC; Jacobs EJ; Newton CC; Guinter MA; Cance WG; Campbell PT
J Natl Cancer Inst; 2021 Jul; 113(7):833-840. PubMed ID: 33528005
[TBL] [Abstract][Full Text] [Related]
36. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
37. Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies.
Ye XF; Wang J; Shi WT; He J
Br J Cancer; 2014 Nov; 111(11):2172-9. PubMed ID: 25180765
[TBL] [Abstract][Full Text] [Related]
38. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
[TBL] [Abstract][Full Text] [Related]
39. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Sørensen HT; Hallas J; Larsen SB; Tjønneland A; Friis S
Cancer Causes Control; 2016 Sep; 27(9):1067-79. PubMed ID: 27503490
[TBL] [Abstract][Full Text] [Related]
40. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Paleari L; Puntoni M; Clavarezza M; DeCensi M; Cuzick J; DeCensi A
Clin Oncol (R Coll Radiol); 2016 May; 28(5):317-26. PubMed ID: 26712086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
